Suppr超能文献

日本患者原发性开角型青光眼初次小梁切除术联合丝裂霉素C的长期随访

Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients.

作者信息

Shigeeda Takashi, Tomidokoro Atsuo, Chen Yi-Ning, Shirato Shiroaki, Araie Makoto

机构信息

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.

出版信息

J Glaucoma. 2006 Jun;15(3):195-9. doi: 10.1097/01.ijg.0000212202.57029.45.

Abstract

PURPOSE

To determine the long-term intraocular pressure (IOP) control and postoperative complications after initial trabeculectomy with use of mitomycin C (MMC) in patients with primary open-angle glaucoma (POAG).

PATIENTS AND METHODS

A retrospective review was conducted of a consecutive series of 123 eyes (87 patients) with POAG who underwent initial trabeculectomy with MMC and had at least 4 years of follow-up. All patients underwent standard trabeculectomy with 0.04% MMC applied intraoperatively for 3 minutes. The long-term outcomes (IOP control and bleb leak, long-standing hypotony, bleb-related infections) were analyzed with the Kaplan-Meier life-table method on the basis of three definitions of successful IOP control (defined as IOP <18 mmHg (definition 1), IOP <16 mmHg (definition 2), and IOP decrease of by > or =30% and <21 mmHg (definition 3)).

RESULTS

The mean follow-up time was 6.8+/-1.4 (mean+/-SD) years. The cumulative survival rates were 67.0+/-4.6%, 44.5+/-5.4%, and 74.1+/-4.2%, respectively, based on definitions 1, 2, and 3, 8 years postoperatively by life-table analysis. At 8 years, bleb leak occurred in 7.9+/-2.6% of eyes, long-standing hypotony in 8.3+/-2.5%, and bleb-related infections in 5.9+/-2.4%.

CONCLUSION

Long-term outcome after initial trabeculectomy with MMC in Japanese POAG patients is comparable with that reported in other populations and with that after trabeculectomy with 5-fluorouracil.

摘要

目的

确定原发性开角型青光眼(POAG)患者初次小梁切除术中使用丝裂霉素C(MMC)后的长期眼压(IOP)控制情况及术后并发症。

患者与方法

对连续123只眼(87例患者)的POAG患者进行回顾性研究,这些患者接受了初次小梁切除术并使用MMC,且至少随访4年。所有患者均接受标准小梁切除术,术中应用0.04%的MMC 3分钟。根据三种成功眼压控制的定义(定义为眼压<18 mmHg(定义1)、眼压<16 mmHg(定义2)、眼压降低≥30%且<21 mmHg(定义3)),采用Kaplan-Meier生存表法分析长期预后(眼压控制和滤过泡渗漏、持续性低眼压、滤过泡相关感染)。

结果

平均随访时间为6.8±1.4(平均±标准差)年。根据生存表分析,术后8年,基于定义1、2和3的累积生存率分别为67.0±4.6%、44.5±5.4%和74.1±4.2%。8年时,7.9±2.6%的眼发生滤过泡渗漏,8.3±2.5%发生持续性低眼压,5.9±2.4%发生滤过泡相关感染。

结论

日本POAG患者初次小梁切除术中使用MMC后的长期预后与其他人群报道的结果以及5-氟尿嘧啶小梁切除术后的结果相当。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验